CARA A MATHEWS
Allopathic & Osteopathic Physicians|Obstetrics & Gynecology PROVIDENCE, RI NPI 1659540490
Browse related groups: Allopathic & Osteopathic Physicians|Obstetrics & Gynecology RI GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$15,710.75
- Category: General Payments
- Program years: PY2018–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $15,557.22 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $11,616.69 | 2 |
| Consulting Fee | $3,491.81 | 2 |
| Food and Beverage | $448.72 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $13,008.50 | 3 |
| ABBVIE INC. | $2,324.72 | 3 |
| AstraZeneca UK Limited | $135.00 | 1 |
| Aadi Bioscience, Inc. | $89.00 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1093979331 | AstraZeneca UK Limited | $135.00 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104983189 | ABBVIE INC. | $169.38 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104983191 | ABBVIE INC. | $2,100.00 | 07/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1104983193 | ABBVIE INC. | $55.34 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115970735 | GlaxoSmithKline, LLC. | $11,338.73 | 08/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1116220006 | GlaxoSmithKline, LLC. | $277.96 | 12/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1116303317 | GlaxoSmithKline, LLC. | $1,391.81 | 12/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1119596663 | Aadi Bioscience, Inc. | $89.00 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.